HIMCH
ALXN

Hartford Investment Management Co (HIMCO)’s Alexion Pharmaceuticals ALXN Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-23,378
Closed -$4.29M – 551
2021
Q2 		$4.29M Sell
23,378
-721
-3% -$124K 0.11% 196
2021
Q1 		$3.69M Sell
24,099
-918
-4% -$142K 0.1% 219
2020
Q4 		$3.91M Buy
25,017
+2,133
+9% +$274K 0.1% 197
2020
Q3 		$2.62M Sell
22,884
-1,087
-5% -$117K 0.09% 227
2020
Q2 		$2.69M Sell
23,971
-39
-0.2% -$4.14K 0.1% 214
2020
Q1 		$2.16M Buy
24,010
+892
+4% +$87.5K 0.07% 251
2019
Q4 		$2.5M Sell
23,118
-926
-4% -$99K 0.06% 289
2019
Q3 		$2.35M Sell
24,044
-359
-1% -$40.5K 0.07% 291
2019
Q2 		$3.2M Buy
24,403
+200
+0.8% +$25.8K 0.09% 234
2019
Q1 		$3.27M Sell
24,203
-296
-1% -$36.8K 0.09% 225
2018
Q4 		$2.38M Sell
24,499
-242
-1% -$28.6K 0.07% 256
2018
Q3 		$3.44M Sell
24,741
-425
-2% -$53.3K 0.1% 217
2018
Q2 		$3.12M Sell
25,166
-16,766
-40% -$1.96M 0.1% 228
2018
Q1 		$4.67M Sell
41,932
-3,935
-9% -$470K 0.09% 253
2017
Q4 		$5.49M Sell
45,867
-2,208
-5% -$269K 0.1% 247
2017
Q3 		$6.74M Sell
48,075
-764
-2% -$104K 0.13% 205
2017
Q2 		$5.94M Sell
48,839
-2,020
-4% -$235K 0.11% 225
2017
Q1 		$6.17M Sell
50,859
-3,679
-7% -$474K 0.12% 215
2016
Q4 		$6.67M Buy
54,538
+371
+0.7% +$45.4K 0.13% 202
2016
Q3 		$6.64M Buy
54,167
+741
+1% +$95.4K 0.13% 188
2016
Q2 		$6.24M Sell
53,426
-1,154
-2% -$164K 0.13% 190
2016
Q1 		$7.6M Buy
54,580
+200
+0.4% +$29.4K 0.16% 154
2015
Q4 		$10.4M Sell
54,380
-5,011
-8% -$875K 0.22% 108
2015
Q3 		$9.29M Buy
59,391
+570
+1% +$104K 0.2% 119
2015
Q2 		$10.6M Buy
58,821
+9,849
+20% +$1.7M 0.22% 117
2015
Q1 		$8.49M Sell
48,972
-997
-2% -$180K 0.17% 142
2014
Q4 		$9.25M Sell
49,969
-765
-2% -$142K 0.18% 129
2014
Q3 		$8.41M Sell
50,734
-1,276
-2% -$210K 0.18% 135
2014
Q2 		$8.13M Sell
52,010
-1,396
-3% -$220K 0.17% 148
2014
Q1 		$8.13M Sell
53,406
-1,301
-2% -$207K 0.17% 143
2013
Q4 		$7.28M Sell
54,707
-3,360
-6% -$403K 0.15% 155
2013
Q3 		$6.75M Sell
58,067
-1,247
-2% -$137K 0.15% 165
2013
Q2 		$5.47M Buy
+59,314
New +$5.72M 0.12% 196

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s ALXN Position: Q3 2021 in Review

Hartford Investment Management Co (HIMCO) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 23,378 shares — an estimated $4.29M sold.

Hartford Investment Management Co (HIMCO) first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $10.6M in Q2 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Hartford Investment Management Co (HIMCO) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 23,378 Alexion Pharmaceuticals shares in Q3 2021, an estimated $4.29M.
  • Hartford Investment Management Co (HIMCO) first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Hartford Investment Management Co (HIMCO)'s Alexion Pharmaceuticals position peaked at $10.6M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q3 2021, filed 1 Nov 2021.